Trial Profile
Phase II trial of ALIMTA [pemetrexed] in relapsed small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Oct 2006
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 16 Oct 2006 Status change
- 05 Nov 2005 New trial record.